To reduce opioid use for lower back pain, we don't have to switch to other risky painkillers

Publicly released:
Australia; International; NSW
Photo by freestocks on Unsplash
Photo by freestocks on Unsplash

A push to reduce the amount of opioids being used to treat lower back pain in Australian emergency rooms does not come with an increase in use of other 'risky' painkillers, according to Australian research. The team took a second look at a trial of a new guideline aimed at reducing opioid use which was held across four Australian emergency departments. The trial saw the use of opioids to treat people presenting with lower back pain reduced from 62.8% of cases to 50.5% without harming patient-reported outcomes. In this second analysis, researchers looked at the types of painkillers the doctors switched to during the trial to see if they were moving from one painkiller that can cause harm to another, such as benzodiazepines and antiepileptics. They say there was no evidence of this happening, with benzo use decreasing during the trial and increases seen in the use of nonsteroidal anti-inflammatory drugs (NSAIDs), which include aspirin and ibuprofen, and paracetamol. The researchers say this shows it's possible to move away from opioids in an emergency room using safer medications.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research JAMA, Web page The URL will go live after the embargo ends
Journal/
conference:
JAMA Health Forum
Research:Paper
Organisation/s: George Institute for Global Health, The University of Sydney, Laval University, Canada
Funder: The SHAPED trial was funded by Sydney Health Partners and the NSW Agency for Clinical Innovation. Flexeze provided heat wraps at no cost for the trial. Ms Côté-Picard is supported by a scholarship from the Québec Research Funds, Health Division. Drs Machado and Maher are supported by Investigator Grants from the Australian National Health and Medical Research Council.
Media Contact/s
Contact details are only visible to registered journalists.